Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02568540 · ClinicalTrials.gov registry record

C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study

A clinical trial, sponsored by Boston Children's Hospital.

Terminated
Registry status
155
Enrollment target

NCT02568540: Clinical Trial study, sponsored by Boston Children's Hospital.

NCT02568540 is a clinical trial that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 155 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02568540 was terminated before completion, sponsored by Boston Children's Hospital.

TERMINATED
Registry status
155 participants
Enrollment target

Study Summary

Today's mobile devices (especially smartphones) are powerful ways to communicate new information to medical researchers. For this study, researchers at Boston Children's Hospital are asking people with hepatitis C to make use of their smartphones to help report information about themselves that may improve how hepatitis C is treated. This study uses a free app called C Tracker that can be installed from the Apple App Store onto the participants iPhone. The main goal of this research study is to use this app to report hepatitis C related health information to the researchers who are conducting this study. The investigators will ask participants about their health,activities, medications, and ways in which hepatitis C has impacted you. This information will be reported anonymously, which means that the researchers doing the study won't know who the participants are.

Primary Outcome

Patient reported hepatitis C medication therapy. Medication type and timing will be compared against other patient-reported outcome measures looking at workforce productivity and physical health and function. Medication changes will be collected every 4 months (3 times a year).

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2015-10
Est. Completion 2019-01-16
Boston Children's Hospital

462 total trials

Why NCT02568540 stopped before completion

NCT02568540 is an observational study that tracks outcomes without assigning an intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02568540 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02568540 about?

NCT02568540 is a clinical study titled "C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study". Today's mobile devices (especially smartphones) are powerful ways to communicate new information to medical researchers. For this study, researchers at Boston Children's Hospital are asking people with hepatitis C to make use of their smartphones to help report information about themselves that may ...

What is the current status of trial NCT02568540?

This trial is currently terminated. The enrollment target is 155 participants. The study started on 2015-10. Estimated completion is 2019-01-16.

Who is sponsoring clinical trial NCT02568540?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03223610 · 155 participants · Phase 1

    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

  • NCT05072483 · 155 participants

    Natural History Study of CADASIL

  • NCT05086497 · 155 participants · NA

    WBSI Guided Personalized Delivery of TTFields

  • NCT05412069 · 155 participants · NA

    Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02568540, the US trial registry maintained by the National Library of Medicine. NCT02568540 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.